XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock Issued
Common Stock in Treasury
Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Beginning balance (in shares) at Dec. 31, 2022   25,000,000        
Beginning balance at Dec. 31, 2022 $ 268,406 $ 250 $ (368,194) $ 326,839 $ (21,187) $ 330,698
Beginning balance (in shares) at Dec. 31, 2022     (12,295,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (61,363)         (61,363)
Currency translation adjustment 1,916       1,916  
Shares issued for employee benefit plan and compensation (in shares)   189,000        
Shares issued for employee benefit plan and compensation 352 $ 2   350    
Purchase of treasury shares (in shares)     (53,000)      
Purchase of treasury shares (812)   $ (812)      
Shares issued to directors (in shares)   8,000        
Shares issued to directors 0          
Employee and director stock-based compensation 2,540     2,540    
Ending balance (in shares) at Mar. 31, 2023   25,197,000        
Ending balance at Mar. 31, 2023 211,039 $ 252 $ (369,006) 329,729 (19,271) 269,335
Ending balance (in shares) at Mar. 31, 2023     (12,348,000)      
Beginning balance (in shares) at Dec. 31, 2022   25,000,000        
Beginning balance at Dec. 31, 2022 268,406 $ 250 $ (368,194) 326,839 (21,187) 330,698
Beginning balance (in shares) at Dec. 31, 2022     (12,295,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (71,774)          
Currency translation adjustment $ (1,201)          
Purchase of treasury shares (in shares) (58,000)          
Purchase of treasury shares $ (855)          
Ending balance (in shares) at Jun. 30, 2023   25,254,000        
Ending balance at Jun. 30, 2023 199,999 $ 253 $ (369,049) 332,259 (22,388) 258,924
Ending balance (in shares) at Jun. 30, 2023     (12,353,000)      
Beginning balance (in shares) at Mar. 31, 2023   25,197,000        
Beginning balance at Mar. 31, 2023 211,039 $ 252 $ (369,006) 329,729 (19,271) 269,335
Beginning balance (in shares) at Mar. 31, 2023     (12,348,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (10,411)         (10,411)
Currency translation adjustment (3,117)       (3,117)  
Shares issued for employee benefit plan and compensation (in shares)   50,000        
Shares issued for employee benefit plan and compensation 373 $ 1   372    
Purchase of treasury shares (in shares)     (5,000)      
Purchase of treasury shares (43)   $ (43)      
Shares issued to directors (in shares)   7,000        
Shares issued to directors 0          
Employee and director stock-based compensation 2,158     2,158    
Ending balance (in shares) at Jun. 30, 2023   25,254,000        
Ending balance at Jun. 30, 2023 199,999 $ 253 $ (369,049) 332,259 (22,388) 258,924
Ending balance (in shares) at Jun. 30, 2023     (12,353,000)      
Beginning balance (in shares) at Dec. 31, 2023   25,346,000        
Beginning balance at Dec. 31, 2023 $ 178,920 $ 253 $ (369,973) 336,938 (20,758) 232,460
Beginning balance (in shares) at Dec. 31, 2023 (12,459,845)   (12,460,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ (8,649)         (8,649)
Currency translation adjustment (1,591)       (1,591)  
Shares issued for employee benefit plan and compensation (in shares)   156,000        
Shares issued for employee benefit plan and compensation 301 $ 2   299    
Purchase of treasury shares (in shares)     (140,000)      
Purchase of treasury shares (1,230)   $ (1,230)      
Shares issued to directors (in shares)   6,000        
Shares issued to directors 0          
Employee and director stock-based compensation 1,904     1,904    
Ending balance (in shares) at Mar. 31, 2024   25,508,000        
Ending balance at Mar. 31, 2024 169,655 $ 255 $ (371,203) 339,141 (22,349) 223,811
Ending balance (in shares) at Mar. 31, 2024     (12,600,000)      
Beginning balance (in shares) at Dec. 31, 2023   25,346,000        
Beginning balance at Dec. 31, 2023 $ 178,920 $ 253 $ (369,973) 336,938 (20,758) 232,460
Beginning balance (in shares) at Dec. 31, 2023 (12,459,845)   (12,460,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ (16,842)          
Currency translation adjustment $ (4,493)          
Purchase of treasury shares (in shares) (195,000)          
Purchase of treasury shares $ (1,841)          
Ending balance (in shares) at Jun. 30, 2024   25,627,000        
Ending balance at Jun. 30, 2024 $ 159,771 $ 256 $ (371,814) 340,962 (25,251) 215,618
Ending balance (in shares) at Jun. 30, 2024 (12,654,970)   (12,655,000)      
Beginning balance (in shares) at Mar. 31, 2024   25,508,000        
Beginning balance at Mar. 31, 2024 $ 169,655 $ 255 $ (371,203) 339,141 (22,349) 223,811
Beginning balance (in shares) at Mar. 31, 2024     (12,600,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (8,193)         (8,193)
Currency translation adjustment (2,902)       (2,902)  
Shares issued for employee benefit plan and compensation (in shares)   111,000        
Shares issued for employee benefit plan and compensation 362 $ 1   361    
Purchase of treasury shares (in shares)     (55,000)      
Purchase of treasury shares (611)   $ (611)      
Shares issued to directors (in shares)   8,000        
Shares issued to directors 0          
Employee and director stock-based compensation 1,460     1,460    
Ending balance (in shares) at Jun. 30, 2024   25,627,000        
Ending balance at Jun. 30, 2024 $ 159,771 $ 256 $ (371,814) $ 340,962 $ (25,251) $ 215,618
Ending balance (in shares) at Jun. 30, 2024 (12,654,970)   (12,655,000)